The NFX Podcast · 25 Jun 2021 · 49 min
NFXBio: Why C2i is the World’s First Platform for Cancer Intelligence
MentionsAsaf ZviranOmri Amirav-Drory
About this episode
The team at C2i Genomics is combining cutting-edge genomics and sophisticated AI to provide the world’s first whole-genome cancer intelligence platform, transforming the way cancer is monitored and treated.
C2i uses a blood test that can detect and quantify tiny amounts of residual cancer to better… More on the show's page
Listen on
Apple Podcasts
The show's page